Main considerable factors for correct laboratory test interpretation under DOA treatment

Por Mani, Helen, Lindhoff-Last, Edelgard
Publicado em 2013

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

Por Mani, Helen, Lindhoff-Last, Edelgard
Publicado em 2014

No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke

Por Bohmann, Ferdinand, Mirceska, Ana, Pfeilschifter, Josef, Lindhoff-Last, Edelgard, Steinmetz, Helmuth, Foerch, Christian, Pfeilschifter, Waltraud
Publicado em 2012

Incidence and causes of heparin-induced skin lesions

Por Schindewolf, Marc, Schwaner, Svantje, Wolter, Manfred, Kroll, Hartmut, Recke, Andreas, Kaufmann, Roland, Boehncke, Wolf-Henning, Lindhoff-Last, Edelgard, Ludwig, Ralf J.
Publicado em 2009

Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters

Por Geisen, Christof, Luxembourg, Beate, Watzka, Matthias, Toennes, Stefan W., Sittinger, Katja, Marinova, Milka, von Ahsen, Nicolas, Lindhoff-Last, Edelgard, Seifried, Erhard, Oldenburg, Johannes
Publicado em 2010

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban

Por Pfeilschifter, Waltraud, Steinstraesser, Thurid, Paulus, Patrick, Zeiner, Pia Susan, Bohmann, Ferdinand, Theisen, Alf, Lindhoff-Last, Edelgard, Penski, Cornelia, Wagner, Marlies, Mittelbronn, Michel, Foerch, Christian
Publicado no J Cereb Blood Flow Metab (2016)

Low Allergenic Potential With Fondaparinux: Results of a Prospective Investigation

Por Schindewolf, Marc, Scheuermann, Julia, Kroll, Hartmut, Garbaraviciene, Jurate, Hecking, Carola, Marzi, Ingo, Wolter, Manfred, Kaufmann, Roland, Boehncke, Wolf-Henning, Lindhoff-Last, Edelgard, Ludwig, Ralf J.
Publicado em 2010